ESPR Financing Cash Flow
Esperion Therapeutics Inc · Financing Cash Flow
ESPR Financing Cash Flow
Latest reported$16.22Mperiod ending
ESPR Quarterly Cash from Financing ($26.76M → $16.22M)
Quarterly financing cash flow
High-resolution chart · PNG
ESPR financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 16,216,999 | |
| 30,162,000 | |
| 10,672,000 | |
| 2,850,000 | |
| -7,500,000 | |
| 34,996,000 | |
| -9,095,000 | |
| -30,023,000 | |
| 90,606,000 | |
| 4,471,000 | |
| -4,312,000 | |
| 809,000 | |
| 49,492,000 | |
| -30,577,000 | |
| 46,511,000 | |
| 18,108,000 | |
| -1,436,000 | |
| 213,410,000 | |
| 3,655,000 | |
| 49,113,000 | |
| 2,045,000 | |
| 170,440,000 | |
| 1,597,000 | |
| 3,674,000 | |
| 26,014,000 | |
| 7,014,000 | |
| 976,000 | |
| 126,536,000 | |
| 1,669,000 | |
| 342,000 | |
| -126,000 | |
| 1,185,000 | |
| 9,293,000 | |
| -81,000 | |
| 164,058,000 | |
| -369,000 | |
| -150,000 | |
| -411,000 | |
| -394,000 | |
| -390,000 | |
| -364,000 | |
| -384,000 | |
| 126,000 | |
| 366,000 | |
| 190,414,000 | |
| 91,897,000 | |
| 134,000 | |
| 5,037,000 | |
| 52,000 | |
| -173,937 | |
| 73,431,885 | |
| 15,883,392 | |
| 0 | |
| 5,714,326 | |
| 4,019,000 | |
| 17,362 | |
| 6,000,000 | |
| 67,401,000 | |
| 110,000 | |
| -152,000 | |
| 324,000 | |
| -216,000 | |
| -212,000 | |
| 1,545,000 | |
| -185,000 | |
| 22,382,000 | |
| 2,297,000 | |
| 522,000 | |
| 471,000 | |
| 56,974,000 | |
| -86,132 | |
| 26,759,132 |